4
Changes in Ownership
Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043297
President and CEO sold 50,677 shares at $4.83 ($244,770)
- President and CEO acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
White Ted · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form | +150,000 | 179,466 | D | ||
| 2023-07-24 | Sale : show line 2 in the form | −50,677 | $4.83 | $244,770 | 128,789 | D |
| Open-market sales · 50,677 sh · avg $4.83 · $244,770 | ||||||
Loading xslF345X05/doc4.xml…